Cardiovascular calcification is a common consequence of aging, diabetes,
hypercholesterolemia, mechanically abnormal valve function, and chronic renal …

Pain is a major health problem in end-stage renal disease (ESRD) affecting half of the
dialysis patients; most of them experience a moderate to severe degree of pain …

Current literature suggests associations between abnormal mineral metabolism (MM) to
cardiovascular disease in dialysis populations, with conflicting results. MM physiology is …

Several observational studies have demonstrated that serum levels of minerals and
parathyroid hormone (PTH) have U-or J-shaped associations with mortality in maintenance …

Objective Arterial stiffness, an independent determinant of cardiovascular risk, is regulated
by both structural and functional factors, including endothelium‐derived nitric oxide …

Background: Coronary artery calcification (CAC) is thought to be associated with greater
cardiovascular mortality in patients with end-stage renal disease than in nonuremic persons …

Both vascular calcification and inflammation are common in patients with chronic kidney
disease (CKD). In patients on dialysis, there is increased coronary artery and peripheral …

We assessed the outcome of pretransplant cardiac assessment in a single center. Three
hundred patients with end-stage renal disease underwent electrocardiogram, Bruce …

Results Cardiovascular risk factors were predominantly found in controls, although the
burden of atherosclerosis was higher in the dialysis group. VC was significantly more …

BACKGROUND:: Most patients with chronic kidney disease (CKD) stage 5 develop
secondary hyperparathyroidism (SHPT). SHPT is an adaptive response to CKD and its …